ArticleThe American journal of case reports2025
Personalized In Vitro Fertilization Protocols in Premature Ovarian Insufficiency and Male-Factor Infertility: A Case Series.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND The current literature lacks extensive case-based evaluations of primary ovarian insufficiency (POI) in the context of severe male-factor infertility. This case series presents 4 patients with extremely low AMH levels and varied male infertility, aiming to illustrate clinical decision-making and treatment outcomes. Adjunct therapies such as growth hormone (GH), dehydroepiandrosterone (DHEA), Sildenafil, and Pentoxifylline were incorporated to assess protocol effectiveness. CASE REPORT All 4 patients had low AMH levels and male partners with differing degrees of oligoasthenoteratozoospermia (OAT), except 1 with normozoospermia. Intracytoplasmic sperm injection (ICSI) was performed in all cases. The treatment protocols varied: 3 used high-dose gonadotropins (FSH 300-375 IU with LH and GH), while 1 used a minimal stimulation protocol (Clomiphene Citrate + FSH 150 IU). Embryo transfer methods included both fresh and frozen (FET). Two cycles failed to implant, 1 led to a biochemical pregnancy (ß-hCG 9.22 mIU/mL), and 1 progressed to clinical pregnancy (25%), following endometrial receptivity enhancement in the normozoospermic case. Protocol adjustments were made based on ovarian response and sperm quality. All sample collections and treatments were conducted at Hasan Sadikin Hospital. CONCLUSIONS This case series highlights the complexity of managing infertility in patients with POI and coexisting male-factor infertility. Personalized stimulation, strategic sperm optimization, and endometrial preparation were critical. One patient achieved a clinical pregnancy and 1 had a biochemical pregnancy, indicating a 50% biological response. Further studies are needed to evaluate advanced therapies, including ovarian rejuvenation and enhanced sperm selection, in this challenging patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.